In the US, Rifapentine (rifapentine systemic) is a member of the drug class rifamycin derivatives and is used to treat Tuberculosis, Active.
US matches:
- Rifapentine
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J04AB05
CAS registry number (Chemical Abstracts Service)
0061379-65-5
Chemical Formula
C47-H64-N4-O12
Molecular Weight
877
Therapeutic Categories
Antibacterial
Antitubercular agent
Chemical Name
Rifamycin, 3-[[4-cyclopentyl-1-piperazinyl)imino]methyl]-
Foreign Names
- Rifapentinum (Latin)
- Rifapentin (German)
- Rifapentine (French)
- Rifapentina (Spanish)
Generic Names
- Rifapentina (OS: DCIT)
- Rifapentine (OS: USAN, BAN)
- DL 473 (IS)
- DL 473-IT (IS)
- L 11473 (IS)
- MDL 473 (IS)
- R 773 (IS)
Brand Name
- Priftin
Sanofi-Aventis, United States
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment